C. Gemayel, A. Pelliccia, and P. D. Thompson, Arrhythmogenic right ventricular cardiomyopathy

, J Am Coll Cardiol, vol.38, pp.1773-1781, 2001.

J. L. Hebert, D. Chemla, O. Gerard, K. Zamani, J. Quillard et al., Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia, Am J Cardiol, vol.93, pp.728-733, 2004.

N. D. Merner, K. A. Hodgkinson, A. F. Haywood, S. Connors, V. M. French et al.,

A. Fletcher, S. Y. Ho, K. P. Mccarthy, and M. N. Sheppard, Spectrum of pathological changes in both ventricles of patients dying suddenly with arrhythmogenic right ventricular dysplasia. Relation of changes to age, Histopathology, vol.48, pp.445-452, 2006.

C. Basso, G. Thiene, D. Corrado, A. Angelini, A. Nava et al., Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?, Circulation, vol.94, pp.983-991, 1996.
URL : https://hal.archives-ouvertes.fr/hal-00514615

G. Amati, C. R. Di-gioia, C. Giordano, and P. Gallo, Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy, Arch Pathol Lab Med, vol.124, pp.287-290, 2000.

N. M. Borradaile and J. E. Schaffer, Lipotoxicity in the heart, Curr Hypertens Rep, vol.7, pp.412-417, 2005.

J. M. Mcgavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak, Adiposity of the heart, revisited, Ann Intern Med, vol.144, pp.517-524, 2006.

B. Desvergne and W. Wahli, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr Rev, vol.20, pp.649-688, 1999.

, Accepted Manuscript 16

J. M. Huss and D. P. Kelly, Nuclear receptor signaling and cardiac energetics, Circ Res, vol.95, pp.568-578, 2004.

P. Lefebvre, G. Chinetti, J. C. Fruchart, and B. Staels, Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis, J Clin Invest, vol.116, pp.571-580, 2006.

F. Djouadi, C. J. Weinheimer, J. E. Saffitz, C. Pitchford, J. Bastin et al., A genderrelated defect in lipid metabolism and glucose homeostasis in peroxisome proliferatoractivated receptor alpha-deficient mice, J Clin Invest, vol.102, pp.1083-1091, 1998.

P. M. Barger and D. P. Kelly, PPAR signaling in the control of cardiac energy metabolism

, Trends Cardiovasc Med, vol.10, pp.238-245, 2000.

B. N. Finck, X. Han, M. Courtois, F. Aimond, J. M. Nerbonne et al., A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content, Proc Natl Acad Sci U S A, vol.100, pp.1226-1231, 2003.

B. N. Finck and D. P. Kelly, Peroxisome proliferator-activated receptor alpha (PPARalpha)

, signaling in the gene regulatory control of energy metabolism in the normal and diseased heart, J Mol Cell Cardiol, vol.34, pp.1249-1257, 2002.

M. J. Goikoetxea, J. Beaumont, A. Gonzalez, B. Lopez, R. Querejeta et al., Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease, Cardiovasc Res, vol.69, pp.899-907, 2006.

M. Schupp, U. Kintscher, J. Fielitz, J. Thomas, R. Pregla et al., Cardiac PPARalpha expression in patients with dilated cardiomyopathy, Eur J Heart Fail, vol.8, pp.290-294, 2006.

J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli, From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions, Prog Lipid Res, vol.45, p.17, 2006.

N. H. Son, T. S. Park, H. Yamashita, M. Yokoyama, L. A. Huggins et al.,

, Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice, J Clin Invest, vol.117, pp.2791-2801, 2007.

S. Z. Duan, C. Y. Ivashchenko, M. W. Russell, D. S. Milstone, and R. M. Mortensen, Cardiomyocytespecific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice, Circ Res, vol.97, pp.372-379, 2005.

D. Gomez-garre, M. Herraiz, M. L. Gonzalez-rubio, R. Bernal, P. Aragoncillo et al., Activation of peroxisome proliferator-activated receptor-alpha and -gamma in auricular tissue from heart failure patients, Eur J Heart Fail, vol.8, pp.154-161, 2006.

M. R. Mehrabi, P. Haslmayer, S. Humpeler, G. Strauss-blasche, W. Marktl et al., Quantitative analysis of peroxisome proliferator-activated receptor gamma (PPARgamma) expression in arteries and hearts of patients with ischaemic or dilated cardiomyopathy, Eur J Heart Fail, vol.5, pp.733-739, 2003.

W. J. Mckenna, G. Thiene, A. Nava, F. Fontaliran, C. Blomstrom-lundqvist et al., Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, Br Heart J, vol.71, pp.215-218, 1994.

D. I. Keller, C. Coirault, T. Rau, T. Cheav, M. Weyand et al., Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties, J Mol Cell Cardiol, vol.36, pp.355-362, 2004.

C. Coirault, F. Lambert, S. Marchand-adam, P. Attal, D. Chemla et al., Myosin molecular motor dysfunction in dystrophic mouse diaphragm, Am J Physiol, vol.277, pp.1170-1176, 1999.

, Accepted Manuscript 18

P. Vanburen, D. E. Harris, N. R. Alpert, and D. M. Warshaw, Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro, Circ Res, vol.77, pp.439-444, 1995.

I. Morano, Tuning the human heart molecular motors by myosin light chains, J Mol Med, vol.77, pp.544-555, 1999.

H. C. Chiu, A. Kovacs, D. A. Ford, F. F. Hsu, R. Garcia et al., A novel mouse model of lipotoxic cardiomyopathy, J Clin Invest, vol.107, pp.813-822, 2001.

A. Guellich, T. Damy, Y. Lecarpentier, M. Conti, V. Claes et al., Role of oxidative stress in cardiac dysfunction of PPARalpha-/-mice, Am J Physiol Heart Circ Physiol, vol.293, pp.93-102, 2007.

D. Dyntar, M. Eppenberger-eberhardt, K. Maedler, M. Pruschy, H. M. Eppenberger et al., Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes, Diabetes, vol.50, pp.2105-2113, 2001.

A. Moretti, H. J. Weig, T. Ott, M. Seyfarth, H. P. Holthoff et al., Essential myosin light chain as a target for caspase-3 in failing myocardium, Proc Natl Acad Sci U S A, vol.99, pp.11860-11865, 2002.

T. Nishikawa, S. Ishiyama, M. Nagata, Y. Sakomura, M. Nakazawa et al., Programmed cell death in the myocardium of arrhythmogenic right ventricular cardiomyopathy in children and adults, Cardiovasc Pathol, vol.8, pp.185-189, 1999.

Z. Mallat, A. Tedgui, F. Fontaliran, R. Frank, M. Durigon et al., Evidence of apoptosis in arrhythmogenic right ventricular dysplasia, N Engl J Med, vol.335, pp.1190-1196, 1996.

A. J. Gilde and M. Van-bilsen, Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle, Acta Physiol Scand, vol.178, pp.425-434, 2003.

C. Forest, J. Tordjman, M. Glorian, E. Duplus, G. Chauvet et al., Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase, Biochem Soc Trans, vol.31, pp.1125-1129, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00088170

, Accepted Manuscript 19

J. Tordjman, W. Khazen, B. Antoine, G. Chauvet, J. Quette et al., Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes, Biochimie, vol.85, pp.1213-1218, 2003.

E. Garcia-gras, R. Lombardi, M. J. Giocondo, J. T. Willerson, M. D. Schneider et al., Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy, J Clin Invest, vol.116, pp.2012-2021, 2006.